Seoul National University Hospital

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 2003-01-01

Employees: 501

Market Cap: -

Website: https://www.snubh.org

Clinical Trials

Clinical, Physiological and Prognostic Implication of Microvascular Status

Conditions: Coronary Artery Disease

First Posted Date: 2014-07-10

Last Posted Date: 2017-11-27

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 1197

Registration Number: NCT02186093

Locations: 🇰🇷
Keimyung University Dongsan medical center, Daegu, Korea, Republic of
🇰🇷
Inje University Ilsan Paik Hospital, Goyang, Korea, Republic of
🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

and more 2 locations

Effect of Prewarming on Microcirculatory Response

Not Applicable

Completed

Conditions: Coronary Artery Bypass Graft Triple Vessel

Interventions: Device: prewarming

First Posted Date: 2014-07-10

Last Posted Date: 2019-03-18

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 40

Registration Number: NCT02186210

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Gemigliptin
Drug: Placebo

First Posted Date: 2014-07-10

Last Posted Date: 2016-04-21

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 10

Registration Number: NCT02186080

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones

Phase 4

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Mosapride citrate
Drug: Linagliptin
Drug: Acetaminophen (paracetamol)

First Posted Date: 2014-07-02

Last Posted Date: 2017-11-29

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 12

Registration Number: NCT02180334

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Gut Hormone, Nociceptors, Neurotrophic Factors Expression in Functional Dyspepsia

Completed

Conditions: H. Pylori Infection
Functional Dyspepsia

First Posted Date: 2014-06-25

Last Posted Date: 2015-01-07

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 314

Registration Number: NCT02173925

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of

Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose)

Phase 4

Completed

Conditions: Cancer

Interventions: Drug: pinaverium bromide
Drug: water

First Posted Date: 2014-06-25

Last Posted Date: 2016-04-15

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 58

Registration Number: NCT02173964

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of

Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)

Phase 4

Completed

Conditions: Postural Orthostatic Tachycardia Syndrome

Interventions: Drug: Propranolol+pyridostigmine
Drug: Propranolol
Drug: Bisoprolol+pyridostgmine
Drug: Bisoprolol

First Posted Date: 2014-06-24

Last Posted Date: 2018-04-18

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 150

Registration Number: NCT02171988

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Safety and Efficacy of Fentanyl Citrate in Children

Phase 2

Completed

Conditions: Children

Interventions: Drug: midazolam and fentanyl citrate infusion
Drug: midazolam and normal saline infusion

First Posted Date: 2014-06-24

Last Posted Date: 2015-11-25

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 44

Registration Number: NCT02172014

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Mannitol Brain Relaxation Effect

Not Applicable

Conditions: Supratentorial Neoplasms

Interventions: Drug: 0.25g/kgof 20% mannitol
Drug: 1.0g/kg of 20% mannitol
Drug: 0.5g/kg of 20% mannitol
Drug: 1.5g/kg of 20% mannitol

First Posted Date: 2014-06-20

Last Posted Date: 2014-10-24

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 124

Registration Number: NCT02168075

Locations: 🇰🇷
Seoul National University of Hospital, Seoul, Korea, Republic of

Immune Response to Hepatitis B Virus Booster Vaccination After 20-23 Years

Not Applicable

Terminated

Conditions: Hepatitis B Vaccination

Interventions: Biological: HBV booster vaccination 1dose

First Posted Date: 2014-06-18

Last Posted Date: 2017-05-15

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 9

Registration Number: NCT02166671

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy